Cargando…

gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism

BACKGROUND: gp91(phox), the catalytic core of NADPH oxidase (NOX) and biomarker of NOX activation, has been recently recognized as a parameter of systemic oxidative stress in several studies. Subclinical hypothyroidism (SH) is characteristic of elevated level of serum thyroid stimulating hormone (TS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaochun, Wang, Furong, Zhen, Xiaowen, Zhao, Lifang, Fang, Li, Dong, Zhenfang, Chen, Wenbin, Zhou, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225862/
https://www.ncbi.nlm.nih.gov/pubmed/32454820
http://dx.doi.org/10.1155/2020/3161730
_version_ 1783534158654472192
author Ma, Xiaochun
Wang, Furong
Zhen, Xiaowen
Zhao, Lifang
Fang, Li
Dong, Zhenfang
Chen, Wenbin
Zhou, Xiaoming
author_facet Ma, Xiaochun
Wang, Furong
Zhen, Xiaowen
Zhao, Lifang
Fang, Li
Dong, Zhenfang
Chen, Wenbin
Zhou, Xiaoming
author_sort Ma, Xiaochun
collection PubMed
description BACKGROUND: gp91(phox), the catalytic core of NADPH oxidase (NOX) and biomarker of NOX activation, has been recently recognized as a parameter of systemic oxidative stress in several studies. Subclinical hypothyroidism (SH) is characteristic of elevated level of serum thyroid stimulating hormone (TSH) and is frequently accompanied with cholesterolemia. In this study, the levels of serum soluble gp91(phox) were measured to assess the oxidative stress in patients with SH. And the relationship among gp91(phox), low-density lipoprotein-C (LDL-C), and TSH was also investigated. METHODS: A total of 51 subjects were enrolled and categorized into four groups: the healthy controls subjects (n = 13), controls with high level of LDL-C alone (n = 12), SH with normal level of LDL-C (n = 11), and SH with high level of LDL-C (n = 15). The related clinical and laboratory data were collected for statistical analysis. All the patients were newly diagnosed and did not take any medication. The information of lipid profile and thyroid function was extracted, and the concentrations of gp91phox were obtained with ELISA. RESULTS: The levels of serum soluble gp91phox evidently increased in the patients with SH with a high level of LDL-C (81.52 ± 37.00 ug/mL) as compared to the healthy controls (54.98 ± 1.83ug/mL, p < 0.001), controls with high level of LDL-C (61.21 ± 4.48 ug/mL, p=0.038) and SH with a normal level of LDL-C (62.82 ± 11.67ug/mL, p=0.027). Additionally, the levels of gp91(phox) showed a significant positive correlation with both the levels of LDL-C (r = 0.595, p < 0.001) and TSH (r = 0.346, p=0.013) by the Spearman correlation analyses. The correlation remained significant even when the effect of another factor was controlled (TSH: when the effect of LDL-C was controlled, r = 0.453, p=0.001; LDL-C: when the effect of TSH was controlled, r = 0.291, p=0.040). The main effect analysis showed an independent main effect of either LDL-C (p = 0.041) or TSH (p=0.022) on gp91(phox) without interaction (p=0.299). CONCLUSIONS: Our work demonstrated that the levels of gp91(phox), a novel biomarker for measuring the oxidative stress, were significantly elevated in the patients with SH. And LDL-C and TSH were both independent predictors of gp91(phox). Abbreviations. BMI : Body mass index; TC : Total cholesterol; LDL-C : Low-density lipoprotein cholesterol; HDL-C : High-density lipoprotein cholesterol; TG : Triglyceride; FBG : Fasting blood glucose; FT3 : Free triiodothyronine; FT4 : Free thyroxine; TSH: Thyroid stimulating hormone; SBP : Systolic blood pressure; DBP : Diastolic blood pressure; SD : Standard deviation; LSD: Least significant difference.
format Online
Article
Text
id pubmed-7225862
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72258622020-05-23 gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism Ma, Xiaochun Wang, Furong Zhen, Xiaowen Zhao, Lifang Fang, Li Dong, Zhenfang Chen, Wenbin Zhou, Xiaoming Int J Endocrinol Research Article BACKGROUND: gp91(phox), the catalytic core of NADPH oxidase (NOX) and biomarker of NOX activation, has been recently recognized as a parameter of systemic oxidative stress in several studies. Subclinical hypothyroidism (SH) is characteristic of elevated level of serum thyroid stimulating hormone (TSH) and is frequently accompanied with cholesterolemia. In this study, the levels of serum soluble gp91(phox) were measured to assess the oxidative stress in patients with SH. And the relationship among gp91(phox), low-density lipoprotein-C (LDL-C), and TSH was also investigated. METHODS: A total of 51 subjects were enrolled and categorized into four groups: the healthy controls subjects (n = 13), controls with high level of LDL-C alone (n = 12), SH with normal level of LDL-C (n = 11), and SH with high level of LDL-C (n = 15). The related clinical and laboratory data were collected for statistical analysis. All the patients were newly diagnosed and did not take any medication. The information of lipid profile and thyroid function was extracted, and the concentrations of gp91phox were obtained with ELISA. RESULTS: The levels of serum soluble gp91phox evidently increased in the patients with SH with a high level of LDL-C (81.52 ± 37.00 ug/mL) as compared to the healthy controls (54.98 ± 1.83ug/mL, p < 0.001), controls with high level of LDL-C (61.21 ± 4.48 ug/mL, p=0.038) and SH with a normal level of LDL-C (62.82 ± 11.67ug/mL, p=0.027). Additionally, the levels of gp91(phox) showed a significant positive correlation with both the levels of LDL-C (r = 0.595, p < 0.001) and TSH (r = 0.346, p=0.013) by the Spearman correlation analyses. The correlation remained significant even when the effect of another factor was controlled (TSH: when the effect of LDL-C was controlled, r = 0.453, p=0.001; LDL-C: when the effect of TSH was controlled, r = 0.291, p=0.040). The main effect analysis showed an independent main effect of either LDL-C (p = 0.041) or TSH (p=0.022) on gp91(phox) without interaction (p=0.299). CONCLUSIONS: Our work demonstrated that the levels of gp91(phox), a novel biomarker for measuring the oxidative stress, were significantly elevated in the patients with SH. And LDL-C and TSH were both independent predictors of gp91(phox). Abbreviations. BMI : Body mass index; TC : Total cholesterol; LDL-C : Low-density lipoprotein cholesterol; HDL-C : High-density lipoprotein cholesterol; TG : Triglyceride; FBG : Fasting blood glucose; FT3 : Free triiodothyronine; FT4 : Free thyroxine; TSH: Thyroid stimulating hormone; SBP : Systolic blood pressure; DBP : Diastolic blood pressure; SD : Standard deviation; LSD: Least significant difference. Hindawi 2020-05-06 /pmc/articles/PMC7225862/ /pubmed/32454820 http://dx.doi.org/10.1155/2020/3161730 Text en Copyright © 2020 Xiaochun Ma et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ma, Xiaochun
Wang, Furong
Zhen, Xiaowen
Zhao, Lifang
Fang, Li
Dong, Zhenfang
Chen, Wenbin
Zhou, Xiaoming
gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism
title gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism
title_full gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism
title_fullStr gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism
title_full_unstemmed gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism
title_short gp91(phox), a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism
title_sort gp91(phox), a novel biomarker evaluating oxidative stress, is elevated in subclinical hypothyroidism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225862/
https://www.ncbi.nlm.nih.gov/pubmed/32454820
http://dx.doi.org/10.1155/2020/3161730
work_keys_str_mv AT maxiaochun gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism
AT wangfurong gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism
AT zhenxiaowen gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism
AT zhaolifang gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism
AT fangli gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism
AT dongzhenfang gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism
AT chenwenbin gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism
AT zhouxiaoming gp91phoxanovelbiomarkerevaluatingoxidativestressiselevatedinsubclinicalhypothyroidism